Sino Biopharmaceutical to Review 1H26 Results and Potential Interim Dividend on 19 August 2026

Bulletin Express08-06 16:47

Sino Biopharmaceutical Limited has notified the market that its board of directors will convene on 19 August 2026. The meeting agenda includes:

• Approval for publication of the unaudited interim results covering the six months ended 30 June 2026. • Consideration of an interim dividend payout for the period, subject to board approval.

The board currently comprises five executive directors—Tse Theresa Y Y, Tse Ping, Cheng Cheung Ling, Tse Eric S Y and Tse Hsin—and six independent non-executive directors—Lu Zhengfei, Lu Hong, Zhang Lu Fu, Li Kwok Tung Donald, Chen Lieping and Lu Bai.

The company made the announcement in Hong Kong on 6 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134544703?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134544703","market":"us","top_or_hot":-1,"title":"Sino Biopharmaceutical to Review 1H26 Results and Potential Interim Dividend on 19 August 2026","media":"Bulletin Express","content":"<p>Sino Biopharmaceutical Limited has notified the market that its board of directors will convene on 19 August 2026. The meeting agenda includes:</p>\n<p>• Approval for publication of the unaudited interim results covering the six months ended 30 June 2026.  \n• Consideration of an interim dividend payout for the period, subject to board approval.</p>\n<p>The board currently comprises five executive directors—Tse Theresa Y Y, Tse Ping, Cheng Cheung Ling, Tse Eric S Y and Tse Hsin—and six independent non-executive directors—Lu Zhengfei, Lu Hong, Zhang Lu Fu, Li Kwok Tung Donald, Chen Lieping and Lu Bai.</p>\n<p>The company made the announcement in Hong Kong on 6 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sino Biopharmaceutical to Review 1H26 Results and Potential Interim Dividend on 19 August 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSino Biopharmaceutical to Review 1H26 Results and Potential Interim Dividend on 19 August 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-06 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sino Biopharmaceutical Limited has notified the market that its board of directors will convene on 19 August 2026. The meeting agenda includes:</p>\n<p>• Approval for publication of the unaudited interim results covering the six months ended 30 June 2026.  \n• Consideration of an interim dividend payout for the period, subject to board approval.</p>\n<p>The board currently comprises five executive directors—Tse Theresa Y Y, Tse Ping, Cheng Cheung Ling, Tse Eric S Y and Tse Hsin—and six independent non-executive directors—Lu Zhengfei, Lu Hong, Zhang Lu Fu, Li Kwok Tung Donald, Chen Lieping and Lu Bai.</p>\n<p>The company made the announcement in Hong Kong on 6 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01177","symbol_name":"中国生物制药","start_time":0,"source_url":"","article_id":"1134544703","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134544703","pubTimestamp":1786006079,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sino Biopharmaceutical Limited has notified the market that its board of directors will convene on 19 August 2026. The meeting agenda includes: • Approval for publication of the unaudited interim...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01177":"中国生物制药"},"translate_title":"中国生物制药将于 2026 年 8 月 19 日审阅 26 年上半年业绩和潜在中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01177":1},"content_text":"Sino Biopharmaceutical Limited has notified the market that its board of directors will convene on 19 August 2026. The meeting agenda includes:\n• Approval for publication of the unaudited interim results covering the six months ended 30 June 2026.  \n• Consideration of an interim dividend payout for the period, subject to board approval.\nThe board currently comprises five executive directors—Tse Theresa Y Y, Tse Ping, Cheng Cheung Ling, Tse Eric S Y and Tse Hsin—and six independent non-executive directors—Lu Zhengfei, Lu Hong, Zhang Lu Fu, Li Kwok Tung Donald, Chen Lieping and Lu Bai.\nThe company made the announcement in Hong Kong on 6 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134544703","isCrawlerRequest":true}